Healthcare provider profile · identity verified

Alla Plotkina, D.O.

Family Practice · STATEN ISLAND, NY · NPI 1881737757

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Eliquis	Apixaban	463	37
Atorvastatin Calcium	Atorvastatin Calcium	347	56
Levothyroxine Sodium	Levothyroxine Sodium	266	37
Metoprolol Tartrate	Metoprolol Tartrate	235	43
Furosemide	Furosemide	222	37
Levetiracetam	Levetiracetam	197	30
Gabapentin	Gabapentin	189	29
Mirtazapine	Mirtazapine	187	28
Silver Sulfadiazine	Silver Sulfadiazine	186	24
Potassium Chloride	Potassium Chloride	184	25
Amlodipine Besylate	Amlodipine Besylate	175	37
Famotidine	Famotidine	171	23
Januvia	Sitagliptin Phosphate	141	11
Losartan Potassium	Losartan Potassium	125	19
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	115	35
Omeprazole	Omeprazole	112	20
Mupirocin	Mupirocin	108	23
Pantoprazole Sodium	Pantoprazole Sodium	107	24
Bumetanide	Bumetanide	100	14
Sodium Chloride	0.9 % Sodium Chloride	96	30
Metoprolol Succinate	Metoprolol Succinate	78	15
Trazodone Hcl	Trazodone Hcl	78	12
Metformin Hcl	Metformin Hcl	77	15
Lisinopril	Lisinopril	76	11
Enoxaparin Sodium	Enoxaparin Sodium	73	11
Spironolactone	Spironolactone	73	16
Buspirone Hcl	Buspirone Hcl	72	suppressed
Sertraline Hcl	Sertraline Hcl	70	12
Tamsulosin Hcl	Tamsulosin Hcl	69	22
Latanoprost	Latanoprost	63	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	60	suppressed
Vraylar	Cariprazine Hcl	60	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	59	suppressed
Clonazepam	Clonazepam	57	suppressed
Lacosamide	Lacosamide	55	suppressed
Midodrine Hcl	Midodrine Hcl	54	12
Sps	Sodium Polystyrene Sulfon/Sorb	54	suppressed
Carvedilol	Carvedilol	52	suppressed
Donepezil Hcl	Donepezil Hcl	52	12
Baclofen	Baclofen	51	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	49	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	46	11
Xarelto	Rivaroxaban	46	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	44	suppressed
Hydralazine Hcl	Hydralazine Hcl	44	suppressed
Albuterol Sulfate	Albuterol Sulfate	43	suppressed
Divalproex Sodium	Divalproex Sodium	42	suppressed
Prednisone	Prednisone	42	11
Ssd	Silver Sulfadiazine	42	12
Alprazolam	Alprazolam	41	suppressed
Austedo	Deutetrabenazine	41	suppressed
Clopidogrel	Clopidogrel Bisulfate	41	12
Santyl	Collagenase Clostridium Hist.	41	suppressed
Duloxetine Hcl	Duloxetine Hcl	40	suppressed
Lubiprostone	Lubiprostone	40	suppressed
Nifedipine Er	Nifedipine	40	suppressed
Budesonide	Budesonide	39	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	39	15
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	39	suppressed
Heparin Sodium	Heparin Sodium,porcine	39	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	39	suppressed
Fentanyl	Fentanyl	37	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	37	suppressed
Lactulose	Lactulose	37	11
Primidone	Primidone	37	suppressed
Tramadol Hcl	Tramadol Hcl	35	suppressed
Methenamine Hippurate	Methenamine Hippurate	34	suppressed
Oxycodone Hcl	Oxycodone Hcl	34	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	33	suppressed
Finasteride	Finasteride	33	suppressed
Procrit	Epoetin Alfa	32	suppressed
Risperidone	Risperidone	32	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	31	suppressed
Cefepime Hcl	Cefepime Hcl	31	14
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	31	suppressed
Pregabalin	Pregabalin	31	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	31	suppressed
Retacrit	Epoetin Alfa-Epbx	30	12
Aripiprazole	Aripiprazole	29	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	27	suppressed
Labetalol Hcl	Labetalol Hcl	27	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	27	suppressed
Bupropion Hcl	Bupropion Hcl	26	suppressed
Dorzolamide Hcl	Dorzolamide Hcl	26	suppressed
Fluticasone Propionate	Fluticasone Propionate	26	suppressed
Lidocaine Hcl Viscous	Lidocaine Hcl	26	suppressed
Torsemide	Torsemide	26	suppressed
Meropenem	Meropenem	25	13
Ondansetron Hcl	Ondansetron Hcl	25	12
Dextrose In Water	Dextrose 5 % In Water	24	suppressed
Glipizide	Glipizide	24	suppressed
Octreotide Acetate	Octreotide Acetate	24	suppressed
Nystatin	Nystatin	23	suppressed
Enalapril Maleate	Enalapril Maleate	22	suppressed
Ertapenem	Ertapenem Sodium	22	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	22	suppressed
Hydrocortisone	Hydrocortisone	22	suppressed
Memantine Hcl	Memantine Hcl	22	suppressed
Topiramate	Topiramate	22	suppressed
Allopurinol	Allopurinol	21	suppressed
Citalopram Hbr	Citalopram Hydrobromide	21	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	21	suppressed
Atrovent Hfa	Ipratropium Bromide	20	suppressed
Humalog Kwikpen U-100	Insulin Lispro	20	suppressed
Myrbetriq	Mirabegron	20	suppressed
Novolog Flexpen	Insulin Aspart	20	suppressed
Tizanidine Hcl	Tizanidine Hcl	20	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	20	suppressed
Vancomycin Hcl	Vancomycin Hcl	19	12
Calcium Acetate	Calcium Acetate	18	suppressed
Entresto	Sacubitril/Valsartan	18	suppressed
Lokelma	Sodium Zirconium Cyclosilicate	18	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	17	suppressed
Insulin Lispro	Insulin Lispro	17	suppressed
Roflumilast	Roflumilast	17	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	17	suppressed
Silodosin	Silodosin	17	suppressed
Simvastatin	Simvastatin	17	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	16	suppressed
Ketoconazole	Ketoconazole	16	suppressed
Alogliptin	Alogliptin Benzoate	15	suppressed
Humalog	Insulin Lispro	15	suppressed
Incruse Ellipta	Umeclidinium Bromide	15	suppressed
Lamotrigine	Lamotrigine	15	suppressed
Avycaz	Ceftazidime/Avibactam	14	suppressed
Betamethasone Dipropionate	Betamethasone Dipropionate	14	suppressed
Ceftriaxone	Ceftriaxone Sodium	14	suppressed
Clonidine Hcl	Clonidine Hcl	14	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	14	suppressed
Epogen	Epoetin Alfa	14	suppressed
Folic Acid	Folic Acid	14	suppressed
Glatiramer Acetate	Glatiramer Acetate	14	suppressed
Linzess	Linaclotide	14	suppressed
Montelukast Sodium	Montelukast Sodium	14	suppressed
Olanzapine	Olanzapine	14	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	14	suppressed
Raloxifene Hcl	Raloxifene Hcl	14	suppressed
Ramipril	Ramipril	14	suppressed
Alendronate Sodium	Alendronate Sodium	13	suppressed
Amiodarone Hcl	Amiodarone Hcl	13	suppressed
Glycopyrrolate	Glycopyrrolate	13	suppressed
Mesalamine	Mesalamine	13	suppressed
Mesalamine Er	Mesalamine	13	suppressed
Rhopressa	Netarsudil Mesylate	13	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	12	suppressed
Gentamicin Sulfate	Gentamicin Sulfate	12	suppressed
Ipratropium Bromide	Ipratropium Bromide	12	suppressed
Jardiance	Empagliflozin	12	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	12	suppressed
Pilocarpine Hcl	Pilocarpine Hcl	12	suppressed
Thiothixene	Thiothixene	12	suppressed
Haloperidol	Haloperidol	11	suppressed
Ibuprofen	Ibuprofen	11	suppressed
Lumigan	Bimatoprost	11	suppressed
Meclizine Hcl	Meclizine Hcl	11	suppressed
Metformin Hcl Er	Metformin Hcl	11	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	11	suppressed
Riluzole	Riluzole	11	suppressed
Valproic Acid	Valproic Acid (As Sodium Salt)	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error